ALK-Abelló A/S (AKBLF)
OTCMKTS · Delayed Price · Currency is USD
35.80
-0.30 (-0.83%)
At close: Jan 26, 2026
ALK-Abelló Employees
ALK-Abelló had 2,764 employees as of September 30, 2025. The number of employees decreased by 31 or -1.11% compared to the same quarter last year.
Employees
2,764
Change
-31
Growth
-1.11%
Revenue / Employee
$345,455
Profits / Employee
$62,577
Market Cap
7.49B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 2,764 | -31 | -1.11% |
| Jun 30, 2025 | 2,782 | -24 | -0.86% |
| Mar 31, 2025 | 2,736 | -92 | -3.25% |
| Dec 31, 2024 | 2,753 | -71 | -2.51% |
| Sep 30, 2024 | 2,795 | 55 | 2.01% |
| Jun 30, 2024 | 2,806 | 79 | 2.90% |
| Mar 31, 2024 | 2,828 | 116 | 4.28% |
| Dec 31, 2023 | 2,824 | 144 | 5.37% |
| Sep 30, 2023 | 2,740 | 136 | 5.22% |
| Jun 30, 2023 | 2,727 | 140 | 5.41% |
| Mar 31, 2023 | 2,712 | 146 | 5.69% |
| Dec 31, 2022 | 2,680 | 143 | 5.64% |
| Sep 30, 2022 | 2,604 | 124 | 5.00% |
| Jun 30, 2022 | 2,587 | 118 | 4.78% |
| Mar 31, 2022 | 2,566 | 107 | 4.35% |
| Dec 31, 2021 | 2,537 | 90 | 3.68% |
| Sep 30, 2021 | 2,480 | 75 | 3.12% |
| Jun 30, 2021 | 2,469 | 64 | 2.66% |
| Mar 31, 2021 | 2,459 | 55 | 2.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
ALK-Abelló News
- 14 days ago - ALK receives positive recommendation for EURneffy® 1 mg: A needle-free anaphylaxis treatment for children - GlobeNewsWire
- 3 months ago - Q3 2025 ALK-Abello A/S Earnings Call Transcript - GuruFocus
- 3 months ago - ALK-Abelló A/S (AKBLF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - ALK-Abelló A/S 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 6 months ago - ALK-Abelló A/S (AKBLF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - ALK-Abelló A/S 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 6 months ago - ALK-Abelló A/S gives Q2 results - Seeking Alpha
- 9 months ago - ALK-Abelló A/S (AKBLF) Q1 2025 Earnings Call Transcript - Seeking Alpha